International Cannabis Weekly: 418

HOW HAS THE UK GOVERNMENT’S POSITION ON CANNABIS CHANGED UNDER LABOUR?

The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads. Does it choose the pharmaceutically focused, highly regulated route, or a more adult-use tinged approach with big brands, big names, and big growth?

READ MORE  »

EXPANDING NHS MEDCIAL CANNABIS ACCESS COULD ADD £13.3 BILLION TO UK ECONOMY

READ MORE »

MINNESOTA’S FIRST NON-TRIBUAL RECREATIONAL DISPENSARY NOW OPEN

READ MORE »

• EFSA has suggested the maximum daily CBD intake should be approximately two milligrams.
• Czech social experiment highlights injustices of continued cannabis prohibition.
• Snoop Dogg’s cannabis firm has invested £4.5 million in UK cannabis clinic expansion.
• Bioxyne Limited has secured German import permits for medical cannabis supply.
• Medical cannabis use declines in Netherlands as Epidyolex costs continue rising.
• Curaleaf Partners with Medical Cannabis Clinicians Society to Strengthen UK Prescriber Education.

GET TICKETS »

GET TICKETS »

• Hawaii health officials push federal marijuana rescheduling as Trump considers reform.
• Democratic senators warn hemp THC ban could devastate entire industry nationwide.
• Minnesota opens first non-tribal recreational marijuana dispensary to the public.
• Eight US senators have urged party leaders to regulate hemp instead of banning.
• Trulieve has introduced five new Onward and Upward cannabis product flavours to the market.
• Michigan lawmakers have supported governor’s plan to increase marijuana tax rates.
• Kentucky prepares for first medical marijuana harvest as crop nears completion.
• Rhode Island has opened application round for up to 24 new adult-use dispensaries. 

• Canopy Growth has improved its balance sheet with early $25 million loan prepayment.
• Cannabis has now become a billion-dollar business in New Brunswick, according to report.
• Verano plans to move parent company registration from British Columbia to Nevada.
• Calgary cannabis sales data is showing that consumption rising across all age groups.
• Health Canada has managed to conduct nearly 900 cannabis inspections in 2025 so far.
• High Tide reports record quarterly revenue, adjusted EBITDA and positive cash flow.
• Calgary cannabis sales data is showing that consumption rising across all age groups.

• Brazilian researchers create portable sensor for quick detection of synthetic cannabinoids.
• São Paulo has hosted Brazil’s largest strategic meeting on medical cannabis and hemp.
• Mendoza publishes detailed regulations for cannabis industry development in Argentina.
• Uruguay has introduced measures to improve adult and medical cannabis accessibility.

• Australian prescribers face stricter responsibilities as MCA confirms roadshow dates.
• Epsilon Healthcare secures GMP certification to strengthen global export readiness.
• Zelira Therapeutics has obtained director loans to enhance working capital reserves.
• Lyphe Australia has  appointed new general manager to drive post-rebuild expansion.

• Cannabis group Labat is now facing new scrutiny from JSE regulators in South Africa.
• IM Cannabis announces board changes and explores new strategic business opportunities.